Clinical Trial Update: Study Evaluating SC262 in Subjects With r/r Non-Hodgkin's Lymphoma (VIVID) [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating SC262 in patients with relapsed/refractory Non-Hodgkin's lymphoma, including Large B-cell lymphoma; currently active but not…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Large B-cell Lymphoma
• Non-hodgkin Lymphoma

Drugs mentioned

• SC262

Snippet

Sponsor: Sana Biotechnology | Conditions: Non Hodgkin's Lymphoma, Large B-cell Lymphoma | Phase 1 | Status: ACTIVE_NOT_RECRUITING